Novartis turns to BioAge for new targets based on longevity and exercise

BioAge Labs, which be­gan near­ly a decade ago as an an­ti-ag­ing biotech and then turned to obe­si­ty this year, is go­ing back to its roots …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.